1. Home
  2. AFMD vs BNRG Comparison

AFMD vs BNRG Comparison

Compare AFMD & BNRG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AFMD
  • BNRG
  • Stock Information
  • Founded
  • AFMD 2000
  • BNRG 2012
  • Country
  • AFMD Germany
  • BNRG Israel
  • Employees
  • AFMD N/A
  • BNRG N/A
  • Industry
  • AFMD Biotechnology: Pharmaceutical Preparations
  • BNRG
  • Sector
  • AFMD Health Care
  • BNRG
  • Exchange
  • AFMD Nasdaq
  • BNRG Nasdaq
  • Market Cap
  • AFMD 10.2M
  • BNRG 10.0M
  • IPO Year
  • AFMD 2014
  • BNRG 2022
  • Fundamental
  • Price
  • AFMD $0.93
  • BNRG $1.34
  • Analyst Decision
  • AFMD Strong Buy
  • BNRG
  • Analyst Count
  • AFMD 5
  • BNRG 0
  • Target Price
  • AFMD $13.50
  • BNRG N/A
  • AVG Volume (30 Days)
  • AFMD 124.6K
  • BNRG 36.5K
  • Earning Date
  • AFMD 06-11-2025
  • BNRG 03-04-2025
  • Dividend Yield
  • AFMD N/A
  • BNRG N/A
  • EPS Growth
  • AFMD N/A
  • BNRG N/A
  • EPS
  • AFMD N/A
  • BNRG N/A
  • Revenue
  • AFMD $6,287,085.00
  • BNRG N/A
  • Revenue This Year
  • AFMD N/A
  • BNRG N/A
  • Revenue Next Year
  • AFMD $225.65
  • BNRG N/A
  • P/E Ratio
  • AFMD N/A
  • BNRG N/A
  • Revenue Growth
  • AFMD N/A
  • BNRG N/A
  • 52 Week Low
  • AFMD $0.52
  • BNRG $0.60
  • 52 Week High
  • AFMD $8.95
  • BNRG $3.27
  • Technical
  • Relative Strength Index (RSI)
  • AFMD 65.06
  • BNRG 50.12
  • Support Level
  • AFMD $0.70
  • BNRG $1.31
  • Resistance Level
  • AFMD $0.85
  • BNRG $1.42
  • Average True Range (ATR)
  • AFMD 0.08
  • BNRG 0.13
  • MACD
  • AFMD 0.04
  • BNRG 0.00
  • Stochastic Oscillator
  • AFMD 89.96
  • BNRG 62.50

About AFMD Affimed N.V.

Affimed NV is a clinical-stage biopharmaceutical company. The company is engaged in discovering and developing targeted cancer immunotherapies. Its product candidates are being developed in the field of immuno-oncology, which represents an approach to cancer treatment that seeks to harness the body's immune defenses to fight tumor cells. It is active in the discovery, pre-clinical and clinical development of antibodies based on its core technology. The Company generates revenues from the provision of research and development services to third parties based on both Group and third party owned intellectual property. Geographically, it derives a majority of revenue from the United States and also has a presence in and Germany.

About BNRG Brenmiller Energy Ltd

Brenmiller Energy Ltd is a technology company that develops, produces, markets, and sells thermal energy storage. The technology of the company allows electrification and decarbonization of the industrial industry sector for integration with renewable energy sources and further reduction of carbon emissions.

Share on Social Networks: